Posts in Biotechnology


The Plight of the Public Sector Entrepreneur

Being an entrepreneur isn't easy. While it is a tough road for anyone, it's particularly tough if you're in the public sector and threatened by politicians... Rather, …
By Joseph Allen
1 day ago 0

University of California seeks assignment of nanopore patents from former grad student

At the center of the legal spat is the proper assignation of a series of patents covering DNA sequencing technologies, which UC alleges were developed while the …
By Steve Brachmann
2 days ago 1

Hysteria over creeping bentgrass leads to Oregon bill targeting GMO patent owners

In early February, a bill was introduced into the Oregon House of Representatives, which could make the state seem much less friendly to patent owners, specifically those …
By Steve Brachmann
6 days ago 5

USF files patent suit over sale of Alzheimer’s research mice

On Tuesday, March 21st, a pre-trial hearing will take place in a case involving patent infringement claims targeting the sale of mice having mutated genes which make …
By Steve Brachmann
8 days ago 0

CRISPR patent interference ended by USPTO because parties’ claims do not interfere

The PTAB concluded: "Based on our determination that the preponderance of the evidence shows there is no interference-in-fact between the parties’ claims, we need not decide the …
By Gene Quinn
1 month ago 3

Sportbrain files smartwatch fitness tracker patent suits against Apple, HP, Michael Kors and New Balance

At the center of each lawsuit is the assertion of a single patent covering personal data collection technology integrated into a series of smartwatches. The patent-in-suit asserted …
By Steve Brachmann
2 months ago 2

FTC revives complaint, files motion for stipulated order over pay-for-delay agreement for generic Lidoderm

On January 23rd, the Federal Trade Commission (FTC) announced that it had taken steps to resolve antitrust charges involving business activities employed by Irish/U.S. drugmaker …
By Steve Brachmann
2 months ago 2

Merck agrees to $625 million payment, royalties to Bristol-Myers Squibb for sales of Keytruda cancer treatment

On January 20th, NYC-based drugmaker Bristol-Myers Squibb Co. (NYSE:BMY) and Kenilworth, NJ-based pharmaceutical firm Merck & Co. (NYSE:MRK) announced that the two companies had entered into …
By Steve Brachmann
2 months ago 0

Other Barks & Bites for Wednesday, January 25th, 2017

On the menu this week for Other Barks & Bites, the Supreme Court hears oral arguments in a case challenging the Lanham Act’s disparagement provision, a six-figure …
By Steve Brachmann
2 months ago 1

Other Barks & Bites for Wednesday, January 18th, 2017

This week’s news headlines include nomination hearings for the potential incoming U.S. Commerce Secretary, the Supreme Court’s granting certiorari for an important case in …
By Steve Brachmann
2 months ago 3

At CES 2017, Alexa reigns supreme over the growing consumer market for AI tech

There can be little doubt that the current conversation surrounding voice assistant technology begins and ends with Alexa, the personal assistant technology developed by Amazon.com. This …
By Steve Brachmann
2 months ago 0

IP News: The Maiden Voyage of the USS IP Watchy McDogface

Without reneging on our commitment to in-depth coverage of the IP world, we wanted to add a new element to our coverage and today we’re introducing …
By Steve Brachmann & Gene Quinn
3 months ago 6

Patent issued on vaccine for one of the most common causes of bronchiolitis and pneumonia

Respiratory syncytial virus, commonly referred to simply as RSV, is a highly contagious viral disease and is one of the most common causes of bronchiolitis and pneumonia. …
By Gene Quinn
3 months ago 1

IBM achieves record number of U.S. patents in 2016, 24th straight year of patent dominance

In 1992, Bill Clinton was elected President of the United States. Hurricane Andrew bore down on the American Southeast, causing billions in damage after wreaking destruction from Florida …
By Steve Brachmann
3 months ago 2

AXIM Biotech earns patent for chewing gum containing cannabinoids to treat neurodegenerative diseases

The patent space surrounding marijuana formulations for medical use is still wide open despite the current march towards legalization. According to patent portfolio analysis tools available through …
By Steve Brachmann
3 months ago 2